VALIANT® Captivia VAMF4242C100TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VAMF4242C100TU VALCAP FREFL · Class 3 · Implant
All models of VALIANT Captivia (95)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 1
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169347342), received between Feb 28, 2017 and Feb 16, 2023 — classified as 1 death, 2 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
Patient problems
- Vascular Dissection3
- Insufficient Information1
- Pain1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryFeb 16, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
VALIANT CAPTIVIA STENT GRAFTS WERE IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A 5.2 CM SACCULAR ANEURYSM . IT WAS REPORTED THAT ON THE DATE OF A ROUTINE CT , A TYPE A DISSECTION WAS OBSERVED. PER THE PHYSICIAN THE CAUSE OF THE TYPE A DISSECTION IS UNKNOWN. NO ADDITIONAL CLINICAL SEQUELAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Vascular Dissection
MAUDE report 16384848 ↗DeathFeb 3, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A VALIANT CAPTIVIA STENT GRAFT WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A TYPE IA ENDOLEAK ON AN UNKNOWN STENT GRAFT. IT WAS REPORTED THE PATIENT PRESENTED EMERGENTLY 2 DAYS POST THE INDEX PROCEDURE WITH SEVERE CHEST PAIN. A CT PERFORMED SHOWED A RETROGRADE TYPE A DISSECTION. THE PHYSICIAN SAID THAT THEY DID BALLOON IN THE ARCH WHERE STENTS OVERLAPPED, WHICH COULD BE A CAUSE. IT WAS QUERIED IF THE RADIAL FORCE OF THE BARE METAL PROXIMAL SPRINGS COULD HAVE CAUSED THE RTAD. AS PER THE PHYSICIAN THE CAUSE OF THE EVENT COULD NOT BE DETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Insufficient Information; Vascular Dissection
MAUDE report 13439820 ↗InjuryFeb 28, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A VALIANT CAPTIVIA STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM. IT WAS REPORTED THAT A FOLLOW UP CT REVEALED A PROXIMAL TYPE I ENDOLEAK PRESENT DUE TO MIGRATION OF THE VALIANT STENT GRAFT. THE PHYSICIAN ELECTED TO IMPLANT ANOTHER VALIANT STENT GRAFT AND PERFORMED A CAROTID TO LEFT SUBCLAVIAN BYPASS. PLACEMENT OF THE VALIANT PROXIMAL EXTENSION PIECE WAS DONE IN A STANDARD MANNER. WHILE ATTEMPTING TO EMBOLIZE THE LSA ORIGIN WITH ANOTHER MANUFACTURER¿S PLUG, THE PLUG WAS DEPLOYED, THE SHEATH WAS WITHDRAWN, A CONTRAST INJECTION DEMONSTRATED POSSIBLE EXTRAVASATION. ANOTHER MANUFACTURER¿S COVERED STENT WAS DEPLOYED IN AN ATTEMPT TO COVER A SUSPECTED VASCULAR PERFORATION, AN ANGIOGRAM DEMONSTRATED POSSIBLE EXTRAVASATION, THEREFORE ANOTHER MANUFACTURER¿S PLUG AND EMBOLIZATION COILS WERE DEPLOYED INSIDE THE COVERED STENT. NO FURTHER EXTRAVASATION WAS OBSERVED. IT WAS REPORTED THAT THE PATIENT PRESENTED EMERGENTLY WITH CHEST PAIN. A CT DEMONSTRATED A SUSPECTED RETROGRADE TYPE A DISSECTION ON THE LESSER CURVE AT THE LOCATION OF THE PROXIMAL STENT GRAFT. THE PHYSICIAN ELECTED TO PERFORM A HEMI-ARCH REPLACEMENT WITH A SURGICAL GRAFT
Patient problems: Pain; Vascular Dissection
MAUDE report 6366280 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page